Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT06874764
Enrolling by invitation Not applicable

Effect of Training With Wireless Lightning Reaction Systems on Cognitive Functions in Individuals With Multiple Sclerosis

NCT06874764 · tracked via the Priya Life Science Turkey tracker
Sponsor
Ege University
Phase
Not applicable
Started
2026-01
Last updated
2026-01-09

Condition(s) studied

Multiple Sclerosis

Investigational drug(s) / intervention(s)

Wireless Lighting Reaction System Training(Agility plus Cognitive)

Wireless Lighting Reaction System Training(Agility plus Cognitive): Agility training and Cognitive trainings(cognitive trainings ready within the device: Eye for detail, Hawk eye, Juggle Factor)

Study summary

When the literature is examined, balance disorders, walking disorders and cognitive problems are frequently observed in Multiple Sclerosis(MS) patients. Using technologically supported equipment such as reaction systems, cognitive function measurements have been successfully performed in the elderly, and improvements in reaction times have been detected in athletes when used for training purposes. The primary aim of the study is to provide improvement in agility and cognitive functions in patients using a technology-supported reaction device. In addition, it aims to improve balance function assessed with static posturography and gait parameters assessed with gait analysis by increasing sensory input and shortening reaction time. As a result of the agility and cognitive training performed, we aim to provide improvement in MS-related quality of life and decrease in disability.

Eligibility

Sex
ALL
Min age
18 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Being between the ages of 18-55 * Having a definite MS diagnosis according to the 2017 McDonald criteria. * EDSS score of 4 or below * Being able to communicate (speaking and understanding Turkish, no speech disorders) Exclusion Criteria: * Regular exercise in the last 6 months * Having an MS attack in the last month * Having an MS attack during the study period * Presence of additional accompanying neurological diseases * Use of dalfampridine * Use of antipsychotic and psychostimulant drugs * Drug and alcohol addiction * Pregnancy, breastfeeding * No chronic systemic disease preventing exercise * Patients who cannot reach the targeted exercise level

Primary outcome measure(s)

  • Cognitive Functions — 8th week
    the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) is a battery with demonstrated validity and reliability in Turkish, consisting of the California Verbal Learning Test II (CVLT II), Symbol Digit Modalities Test (SDMT) and Brief Visuospatial Memory Test-Revised (BVMTR) subscales, used to assess cognitive status in MS patients SDMT: There is no lower or upper limit for scoring. A higher number of correct answers (higher scores) is associated with better results. CVLTII:The upper limit for scoring is 80. A higher number of correct answers (higher scores) is associated with better results. BVMTR:The score range is 0-12. Higher scores are associated with better outcomes.

Trial sites (1)

FacilityCityRegionStatus
Ege University Sport Medicine Clinic Izmir Bornova

More Ege University trials in Turkey

Acute Effects of Oculomotor Exercises on Posturography and Gait Analysis Parameters in Regular Exercisers Active, not recruiting
Assessment of Intrinsic Risk Factors for Ankle Injuries in Ballet Dancers Active, not recruiting
Clinical Evaluation of Three-Dimensional (3D) Printing Resin Nanoceramic Crown Restoration. Active, not recruiting
Effects of Body Mechanics Training on Shoulder-Back Pain and Breastfeeding Ergonomics in Breastfeeding Mothers Active, not recruiting
Effect Of Trendelenburg Position And Pneumoperitoneum On Optic Nerve Sheath Diameter In Robot-Assisted Prostatectomy Recruiting

Other trials for the same condition

Fatigue and Mental Well-Being in MS Patients(Multiple Sclerosis) Recruiting
Effect of Multimodal Exercise Training in Patients With Multiple Sclerosis Recruiting
Cone Evasion Walk Test in Multiple Sclerosis Starting soon
Respiratory Muscle Strength and Endurance Cut-Offs in Multiple Sclerosis Starting soon
Effect of a Mobile Health App on Pain and Quality of Life in Patients With Neuropathic Pain in Multiple Sclerosis Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06874764 on ClinicalTrials.gov ↗ ← All trials in Turkey